Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|February 14, 2025
Ketamine in insulin resistance: Pharmacokinetics, cardiovascular implications and cellular effects on cardiomyocytesAriana Ramirez, Stephanie Howes, Robert ChiltonCurrent Opinion in Nephrology and Hypertension|January 26, 2016
Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertensionIlkka Tikkanen, Robert Chilton, Odd Erik JohansenCurrent Atherosclerosis Reports|March 3, 2006
The good fat hormone: adiponectin and cardiovascular diseaseDat Do, Jorge Alvarez, Elaine Chiquette, et al.Journal of Diabetes and Its Complications|June 4, 2013
New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)Robert R Henry, Robert Chilton, W Timothy GarveyCardiovascular Endocrinology & Metabolism|June 16, 2020
A focused review of cardiovascular guideline related recommendations for the primary care physician in the USAOmar Sheikh, Mouhamed Nashawi, Ayman Battisha, et al.Integrated Blood Pressure Control|June 10, 2014
Aortic stiffness: pathophysiology, clinical implications, and approach to treatmentSalil Sethi, Oscar Rivera, Rene Oliveros, et al.Cardiovascular Endocrinology & Metabolism|August 12, 2024
The web of intrigue: unraveling the role of NETosis within the gut-microbiome-immune-heart axis in acute myocardial infarction and heart failureTai Yasuda, Kate Deans, Aditi Shankar, et al.Postgraduate Medicine|June 12, 2014
Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labelingDavid A Johnson, Robert Chilton, Harley R LikerJACC. Case Reports|May 23, 2025
Accidental Carbon Monoxide Poisoning Leading to Devastating Cardiovascular ConsequencesDebanshu Roy, Daniel J McGowan, Robert Chilton, et al.Current Atherosclerosis Reports|January 10, 2013
Imaging of vulnerable plaques using near-infrared spectroscopy for risk stratification of atherosclerosisSaurabh Sanon, Tim Dao, Vani P Sanon, et al.Pageof 6